Olli Kärkkäinen
banner
ollikarkkainen.bsky.social
Olli Kärkkäinen
@ollikarkkainen.bsky.social
Toxicometabolomics associate professor (tenure track) at the University of Eastern Finland and co-founder and CEO of Afekta Technologies Ltd. Metabolomics, alcohol, drugs, chemicals, treatment, disease progression. https://orcid.org/0000-0003-0825-4956
We were able to get good metabolite profiles from microscopically small chicken gut samples. And show metabolite profile effects of Salmonella infection in different parts of the gut (central lumen, mucosal lumen or host tissue) and that synbiotic treatment can alleviate some of these changes.
June 25, 2025 at 5:24 PM
Thank you!

For the human post-mortem study, unfortunately the ethical approval does not allow for public sharing of the data.

For the pig heart study, there is a plan for public release of the metabolomics data of also other analysed organs in the near future.
June 20, 2025 at 8:17 PM
And of course we also celebrated the Midsummer!
June 20, 2025 at 7:45 PM
... And a first first author paper for talented doctoral researcher Reta Haikonen: Blueprint of the distinct metabolite profiles of healthy pig heart chambers:
doi.org/10.1016/j.jm...
Redirecting
doi.org
June 20, 2025 at 7:42 PM
This is the first first author manuscript for the excellent doctoral researcher Dennisse Avella! This study was part of the @human-dn.bsky.social with great co-authors: Soile Turunen, Glykeria Avgerinou, Anatoli Petridou, Vassilis Mougios, Iman Zarei, Seppo Auriola and Kati Hanhineva
June 16, 2025 at 6:35 PM